Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3220 results found

2025 ∙ Khuu, E. Moussaoui, S. Vignier, N. Bonello, K. Archer, E.

Vaccine hesitancy among migrant populations in Europe: A mixed-methods systematic review

  • Europe
  • All age groups
  • Parents/caregivers
  • Healthcare workers
  • Pregnant women
  • Acceptance
  • Coverage
  • Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Awosan, W. R. Akinyosoye, F. O. Nana, D. W. Enaworu, O. R. Emokpae, B. E. Commey, N. K. Olasehinde, O. E.

Vaccine hesitancy among pregnant women in the U.S. and its implication for maternal and child health

  • Americas
  • United States of America
  • Pregnant women
  • Acceptance
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Rehman, S. Sukaina, M. Aminpoor, H. Davis, S. Munir, A. B. I. Karimi, H.

Vaccine Induced Immune Thrombotic Thrombocytopenia After Sinopharm Vaccination: A Systematic Review of Case Reports

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Low
2025 ∙ Halliday, R. Morais, B. Bouaddi, O. Deal, A. Faijue, D. Bojang, S. Hargreaves, S.

Vaccine-preventable diseases in migrants in Europe: a systematic review

  • Europe
  • All age groups
  • Diphtheria
  • Measles
  • Mumps
  • Pertussis
  • Rubella
  • Tetanus
  • Coverage
  • Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Bynum, C. Bail, J. Prevost, S.

Vaccines and voices: A systematic literature review of sociocultural influences on adult immunization hesitancy

  • Americas
  • United States of America
  • Adults
  • Older adults
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Zorger, A. M. Hirsch, C. Baumann, M. Feldmann, M. Bröckelmann, P. J. Mellinghoff, S. Monsef, I. Skoetz, N. Kreuzberger, N.

Vaccines for preventing infections in adults with haematological malignancies

  • Adults
  • Older adults
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
High
2025 ∙ Hirsch, C. Zorger, A. M. Baumann, M. Park, Y. S. Bröckelmann, P. J. Mellinghoff, S. Monsef, I. Skoetz, N. Kreuzberger, N.

Vaccines for preventing infections in adults with solid tumours

  • Adults
  • Older adults
  • Pneumococcal disease
  • Haemophilus influenzae type B
  • Meningococcal disease
  • Pertussis
  • Hepatitis B
  • Tetanus
  • Poliomyelitis
  • Diphtheria
  • Influenza
  • Herpes zoster
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
High
2025 ∙ de Bondt, D. Naslazi, E. Jansen, E. Kupets, R. McCurdy, B. Stogios, C. de Kok, I. Hontelez, J.

Validating the predicted impact of HPV vaccination on HPV prevalence, cervical lesions, and cervical cancer: A systematic review of population level data and modelling studies

  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Coverage
  • Modeling
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Bolormaa, E. Lee, Y. H. Choe, Y. J. Choe, S. A.

Varicella Vaccine Effectiveness and Duration of Protection: A Systematic Review and Meta-Analysis

  • All age groups
  • Varicella
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Dobritoiu, R. Pacurar, D. Vlad, R. M. Plesca, D. A.

Vertical Transmission of Hepatitis B and C-Then and Now-A Comprehensive Literature Systematic Review

  • Pregnant women
  • Newborn
  • Hepatitis B
  • Hepatitis C
  • Administration
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...